AYURF (Ayurcann Holdings) Market Cap: $0.41 Mil (As of Jul. 05, 2026)


What is Ayurcann Holdings Market Cap?

Ayurcann Holdings AYURF Market Cap is $0.41 Mil as of Jul. 05, 2026. The stock has 2 warning signs investors should review.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ayurcann Holdings's share price for the quarter that ended in Sep. 2025 was $0.0297. Ayurcann Holdings's Shares Outstanding (EOP) for the quarter that ended in Sep. 2025 was 194.70 Mil. Therefore, Ayurcann Holdings's market cap for the quarter that ended in Sep. 2025 was $5.78 Mil.

Ayurcann Holdings's quarterly market cap increased from Mar. 2025 ($3.41 Mil) to Jun. 2025 ($3.54 Mil) and increased from Jun. 2025 ($3.54 Mil) to Sep. 2025 ($5.78 Mil).

Ayurcann Holdings's annual market cap increased from Jun. 2023 ($6.18 Mil) to Jun. 2024 ($9.09 Mil) but then declined from Jun. 2024 ($9.09 Mil) to Jun. 2025 ($3.54 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ayurcann Holdings's Enterprise Value for Today is $0.29 Mil.


Ayurcann Holdings  (OTCPK:AYURF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Ayurcann Holdings Market Cap Related Terms


Ayurcann Holdings Market Cap Historical Data

* Premium members only.

The historical data trend for Ayurcann Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ayurcann Holdings Market Cap Chart

Ayurcann Holdings Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Jun21 Jun22 Jun23 Jun24 Jun25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.67 9.79 6.18 9.09 3.54

Ayurcann Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.13 3.15 3.41 3.54 5.78

AYURF vs BSPK, SKYI, CPMD: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ayurcann Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ayurcann Holdings Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ayurcann Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Ayurcann Holdings's Market Cap falls into.



Ayurcann Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Ayurcann Holdings's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as

Market Cap (A: Jun. 2025 )=Share Price (A: Jun. 2025 )*Shares Outstanding (EOP) (A: Jun. 2025 )
=$0.0182*194.704
=$3.54

Ayurcann Holdings's Market Cap for the quarter that ended in Sep. 2025 is calculated as

Market Cap (Q: Sep. 2025 )=Share Price (Q: Sep. 2025 )*Shares Outstanding (EOP) (Q: Sep. 2025 )
=$0.0297*194.704
=$5.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.41 Mil mean?
Ayurcann Holdings (AYURF) has a Market Cap of $0.41 Mil as of Jul. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ayurcann Holdings and its competitors.
Is Ayurcann Holdings' Market Cap too high?
Ayurcann Holdings' current Market Cap is $0.41 Mil. The Drug Manufacturers industry median Market Cap is 217.83. Ayurcann Holdings' value of $0.41 Mil is 99.8% below this industry median.
How does Ayurcann Holdings' Market Cap compare to BSPK and SKYI?
Ayurcann Holdings' Market Cap of $0.41 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 217.83. Ayurcann Holdings' value of $0.41 Mil is 99.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 217.83, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ayurcann Holdings's current Market Cap of $0.41 Mil is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ayurcann Holdings and its competitors. For the Drug Manufacturers industry, the median Market Cap is 217.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ayurcann Holdings's current Market Cap is $0.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ayurcann Holdings stock overvalued right now?
Ayurcann Holdings (AYURF) has a current Market Cap of $0.41 Mil. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 79% below its estimated fair value. The current Market Cap is $0.41 Mil and 99.8% below the Drug Manufacturers industry median of 217.83. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Ayurcann Holdings (AYURF), the current Market Cap is $0.41 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ayurcann Holdings Business Description

Address 1080 Brock Road, Unit 6, Pickering, ON, CAN, L1W 3H3
Ayurcann Holdings Corp is engaged in providing post-harvest outsourcing solutions to licensed cannabis producers and the manufacture and distribution of cannabis products.